Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

NCT07284901 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1700

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity With Diabetes
Overweight With Diabetes

Interventions

DRUG: KAI-9531
DRUG: Placebo

Sponsor

Kailera